We speculated that NLRP3 inflammasome inhibition ameliorates obesity‐induced cardiac remodeling; however, cardiac aging and sustained HFD for 52 weeks partially reduced its cardioprotective effects. This evidence concerns the gene NLRP3 and obesity due to melanocortin 4 receptor deficiency.